All lobbying filings
FEROX STRATEGIES
FEROX STRATEGIES filed a Q3 report for SURGENEX on October 19, 2026, reporting $50,000 in lobbying income.
Lobbying for SURGENEX · Medical biotechnology manufacturer
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
Arizona
Lobbyists on this filing
1
-
DEBRA DIXON New on this filingPreviously held: Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of Justice
Government bodies contacted
3
Lobbying activity
1
General issues related to skin substitutes.